These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7203701)

  • 1. Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--IV. 2'-123I-iodo-2'-deoxyuridine.
    Abrams DN; Knaus EE; Wiebe LI; Helus F; Maier-Borst W
    Int J Appl Radiat Isot; 1981 Feb; 32(2):105-8. PubMed ID: 7203701
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological stability of 5-iodo-2'-deoxyuridine labelled with iodine-125 after its incorporation into the deoxyribonucleic acid of the mouse.
    Commerford SL
    Nature; 1965 May; 206(987):949-50. PubMed ID: 5839861
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil.
    Abrams DN; Lee YW; Mercer JR; Knaus EE; Wiebe LI
    Br J Radiol; 1986 Mar; 59(699):263-70. PubMed ID: 2936414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine formation in rats bearing the Walker mammary carcinosarcoma.
    Johnston M
    Experientia; 1967 Feb; 23(2):152-4. PubMed ID: 6032118
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of new fluorene disulphonamido derivatives in rats with transplanted Walker carcinosarcoma.
    Malejka D
    Br J Cancer; 1966 Dec; 20(4):857-70. PubMed ID: 5964617
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentration of [14C]actinomycin D in various tissues following intravenous injection.
    Ro TS; Busch H
    Biochim Biophys Acta; 1965 Oct; 108(2):317-8. PubMed ID: 5893631
    [No Abstract]   [Full Text] [Related]  

  • 7. Retention of labelled 5-iodo-2-deoxyuridine after intratumorous injection as a possible indicator of the cellular kinetics.
    Andrysek O; Bláhová E; Gregora V
    Czech Med; 1984; 7(3):161-6. PubMed ID: 6499600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the pyrimidine nucleosides 5-fluoro-2'-deoxyuridine and 5-iodo-2'-deoxyuridine.
    PAPAC R; JACOBS E; WONG F; COLLOM A; SKOOG W; WOOD DA
    Cancer Chemother Rep; 1962 Jul; 20():143-6. PubMed ID: 14483657
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorporation of 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine into rodent DNA as determined by neutron activation analysis.
    Kitchin KT; Brown JL
    Anal Biochem; 1995 Aug; 229(2):180-7. PubMed ID: 7485970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver.
    Zager JS; Delman KA; Ebright MI; Malhotra S; Larson S; Fong Y
    Br J Surg; 2003 Oct; 90(10):1225-31. PubMed ID: 14515291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of injected 4-iodoantipyrine (131-I) in rats.
    Anghileri J; Recchi N; Baruel J
    Experientia; 1966 Feb; 22(2):78-80. PubMed ID: 5927970
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion of 5-iodo-2-pyrimidinone-2'-deoxyribose to 5-iodo-deoxyuridine by aldehyde oxidase. Implication in hepatotropic drug design.
    Chang CN; Doong SL; Cheng YC
    Biochem Pharmacol; 1992 May; 43(10):2269-73. PubMed ID: 1599512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VI. 1-(3'-[36Cl]-chloro-, 1-(3'-[82Br]-bromo- and 1-(3'-[123I]-Iodo-3'-deoxy-beta-D-arabinofuranosyl)uracil.
    Lee YW; Mercer JR; Wiebe LI; Knaus EE
    Int J Appl Radiat Isot; 1984 Nov; 35(11):1057-61. PubMed ID: 6526522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific targeting of the antiviral drug 5-iodo 2'-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine.
    Biessen EA; Beuting DM; Vietsch H; Bijsterbosch MK; Van Berkel TJ
    J Hepatol; 1994 Nov; 21(5):806-15. PubMed ID: 7890898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of thyroid-stimulating globulin from thyrotoxic sera by organ homogenates.
    el Kabir DJ; Benhamou-Glynn N; Doniach D; Roitt IM
    Nature; 1966 Apr; 210(5033):319-21. PubMed ID: 5954578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies with 3H-labeled methylhydrazine derivatives].
    Kleibel F
    Nucl Med (Stuttg); 1965; 2():63-7. PubMed ID: 5888981
    [No Abstract]   [Full Text] [Related]  

  • 17. The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256.
    Minne H; Raue F; Bellwinkel S; Ziegler R
    Acta Endocrinol (Copenh); 1975 Mar; 78(3):613-24. PubMed ID: 1173020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of plasma glycoproteins. II. Studies on the rate of incorporation of glucosamine-1-14C into protein-bound hexosamine in the rat bearing Walker 256 carcinoma.
    Bekesi JG; Macbeth RA; Bice S
    Cancer Res; 1966 Nov; 26(11):2307-15. PubMed ID: 5956635
    [No Abstract]   [Full Text] [Related]  

  • 19. THE EFFECT OF NATURAL AND UNNNATURAL PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES ON THE PHOSPHOROLYSIS OF 5-IODODEOXYURIDINE BY MOUSE LIVER EXTRACT.
    KRISS JP; BOND SB
    Biochem Pharmacol; 1964 Mar; 13():365-70. PubMed ID: 14157596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of 5-iodo-2-deoxyuridine introduced into the eye tissues with soft contact lenses (experimental study)].
    Shchipanova AI; Maĭchuk IuF; Babich GA; Kivaev AA; Zelenskaia MV
    Vestn Oftalmol; 1982; (6):74-6. PubMed ID: 7157576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.